What is YPSN.SW's gross margin?

Ypsomed (YPSN.SW) has a gross margin of 45% and a net margin of 22%.

What is YPSN.SW's P/E ratio?

YPSN.SW's P/E ratio is 21.9 with ROE of 40%.

Where can I see YPSN.SW's full financials?

See Ypsomed (YPSN.SW) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Ypsomed (YPSN.SW) Financials — Revenue, Earnings, Cash Flow

Also trades as: 0QLQ.L (LSE) · $vol 1M · YPHDF (OTC) · $vol 0M

CHF 357.80 ($431.88)

-3.00 (-0.83%)

Weekly Expected Move ±4.4%

CHF 326 CHF 342 CHF 358 CHF 373 CHF 389

SIX · Healthcare · Medical - Specialties · Tech Score Sell · Power 37 · CHF 4.7B mcap · 4M float · 0.409% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

CHF 1B

Revenue

+51.4% YoY

CHF 277M

Net Income

+190.5% YoY

CHF -15M

Free Cash Flow

-499.5% YoY

44.6%

Gross Margin

29.8%

Op. Margin

22.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE40.4%

ROA21.9%

ROIC23.5%

Valuation

P/E21.9

P/B6.5

EV/EBITDA9.2

Leverage

Debt/Equity0.35

Current Ratio1.07

Interest Cov.36.7x

Quality Scores

Piotroski F9/9

Altman Z6.33

Beneish M-2.41